Competition authority approves Meda’s acquisition of Recip

12/7/2007 11:12 AM EST

The Swedish Competition Authority has announced that nothing hinders Meda from acquiring Recip AB. The acquisition will be completed within short.

MEDA

Meda is one of Europe's leading specialty pharma companies, with focus on marketing and market-adapted product development. Long-term partnerships and acquisitions are fundamental factors in its strategy.

View more


  CONTACT  

Related documents

 
 
 

Recent Releases

 
Social Media Pitch:
Competition authority approves Meda’s acquisition of Recip